[Bronchial asthma: pathogenetic mechanisms and genetic aspects]

Area of Science:

• Immunology
• Allergy
• Respiratory Medicine

Background:

• Asthma is characterized by inflammation, with atopy linked to Th2 cells and IgE production.
• Interleukin-4 (IL-4) is key for Th2 cell differentiation, though other cytokines may contribute.
• Genetic factors, including IL-4 gene polymorphisms, are investigated for their role in atopic conditions.

Purpose of the Study:

• To investigate the role of cytokines, particularly IL-4 and IL-5, in the immunological mechanisms of bronchial asthma.
• To explore the pathways leading to eosinophilic inflammation in various asthma types.
• To identify potential therapeutic targets for asthma based on current immunological understanding.

Main Methods:

• Review of current scientific consensus and experimental findings on asthma immunology.
• Analysis of the roles of specific cytokines (IL-4, IL-5) in T cell differentiation and inflammatory responses.
• Investigation of genetic factors, such as IL-4 gene polymorphisms, in atopic individuals.

Main Results:

• IL-4 is essential for atopic state development and maintenance.
• IL-5 plays a critical role in the pathogenesis of bronchial inflammation across atopic, intrinsic, and occupational asthma.
• Multiple pathways can lead to eosinophilic inflammation, all involving sustained IL-5 production.

Conclusions:

• IL-5 is a pivotal mediator of eosinophilic inflammation in asthma.
• Understanding the inducers of IL-5-producing T cells is crucial for intrinsic asthma research.
• IL-5 represents a significant therapeutic target for novel asthma treatments.